SNY Sanofi
- 48.430
- +0.140+0.29%
- 48.700
- +0.270+0.56%
Sanofi News
A Look Into Sanofi Inc's Price Over Earnings
AlphaValue/Baader Europe Trims Sanofi PT, Reiterates Buy Rating
The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian
Top Research Reports for ServiceNow, AMD & Sanofi
Express News | Fulcrum Therapeutics Inc - Sanofi to Terminate Collaboration and License Agreement With Fulcrum
Sanofi Appoints Jean-Paul Kress to Board of Directors
Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III
Sanofi, SK Bioscience Extend Collaboration to Develop Pneumococcal Disease Vaccine for Toddlers, Infants
Press Release: Sanofi Initiates Phase 3 Program for PCV21 and Expands Collaboration With SK Bioscience for Next-generation Pneumococcal Conjugate Vaccines
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Sanofi Signs Deal for Greater China Rights to Aficamten
Sanofi's Tolebrutinib Receives FDA Breakthrough Therapy Designation for NrSPMS
Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China
Cytokinetics Announces Sanofi's Acquisition Of Aficamten Rights For HCM Treatment In Greater China
Express News | Cytokinetics Inc - Eligible for up to $150 Million in Milestone Payments From Sanofi
Express News | Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024
Sanofi: Appointment Is Subject to Ratification at Ordinary Shareholders' Meeting
No Data
